GFAP Antibody (Rabbit Monoclonal)

GFAP Antibody

The GFAP Antibody (Rabbit Monoclonal, Clone EP672Y) from GeneBioSolution is a high-quality antibody optimized for immunohistochemistry (IHC) on formalin-fixed, paraffin-embedded (FFPE) tissues. Glial Fibrillary Acidic Protein (GFAP) is an intermediate filament protein expressed predominantly in astrocytes and glial cells, making it a critical marker in neuropathology. This antibody provides sensitive and specific cytoplasmic staining of GFAP in astrocytes, with minimal background. The EP672Y clone is widely recognized as a reliable marker for the identification of astrocytomas, gliomas, ependymomas, and other glial neoplasms. It is also useful in distinguishing glial tumors from non-glial central nervous system (CNS) tumors. Beyond diagnostic pathology, GFAP expression is also valuable in neuroscience research, where it is used to study astrocyte biology, neural injury, and neurodegenerative disorders. All GeneBioSolution antibodies undergo rigorous validation and quality control, ensuring lot-to-lot consistency, strong reproducible staining, and compatibility with both manual and automated IHC platforms. Clinical & Research Applications Diagnostic aid in gliomas, astrocytomas, and ependymomas Differentiation of glial tumors from non-glial CNS neoplasms Research on astrocyte biology, CNS development, and neurodegeneration Marker of reactive gliosis and CNS injury Key Features Clone: EP672Y (Rabbit Monoclonal) Application: IHC on FFPE tissues Target Protein: GFAP – glial fibrillary acidic protein Diagnostic Utility: Gliomas, astrocytomas, ependymomas, CNS tumor differentiation Performance: Strong cytoplasmic staining, high specificity, reproducible results